Evidence of disordered symptom appraisal in fibromyalgia: Increased rates of reported comorbidity and comorbidity severity
F. Wolfe1, D.J. Hawley2
1Arthritis Research Center and University of Kansas School of Medicine, Wichita; 2School of Nursing, Wichita State University, Wichita, Kansas, USA.
ABSTRACT
Objective
Using a large series of unselected consecutive patients, to investigate whether
patients with fibromyalgia differ from those with rheumatoid arthritis (RA) or
osteoarthritis (OA) in the number of reported comorbid conditions and in their perceived
importance, and thereby to investigate differences in symptom appraisal and somatization.
Method
In a clinical care setting, 1,298 patients with fibromyalgia and 2,396 with RA or OA
participating in longitudinal data bank research as part of their routine medical care
completed questionnaires concerning the presence or absence of 23 comorbid conditions, and
then rated the current importance of each condition to them. Additional information
concerning psychological factors and disease severity was also obtained.
Results
In analyses adjusted for age and sex, patients with fibromyalgia reported more
conditions (4.5 vs. 3.1) than those with RA or OA. In 17 of 23 conditions, the condition
was more commonly reported in fibromyalgia than in RA or OA. In 20 of the 23 conditions,
the importance attached to the conditions by fibromyalgia patients exceeded that of the
importance attributed by RA/OA patients. After adjustment for anxiety, statistical
differences between the groups for importance was lost for 6 conditions.
Conclusions
Fibromyalgia patients report more medical conditions and report that they are more
important to them than do patients with RA or OA. These differences extend to conditions
that might be expected to cause symptoms, as well as to those that are usually symptom
free. These data suggest that, on average, patients with fibromyalgia appraise medical
symptoms and their importance differently from patients with other rheumatic conditions.
Key words
Fibromyalgia, symptom appraisal, comorbidity, somatization.
Please address correspondence to: Frederick Wolfe, M.D., Arthritis Research Center, 1035 North Emporia, Suite 230, Wichita, KS 67214, USA.
Clin Exp Rheumatol 1999; 17: 297-303.
© Copyright Clinical
and Experimental Rheumatology
1999.